Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
Conformis, Inc. (NASDAQ: CFMS), a leader in personalized orthopedic medical devices, announced that CEO Mark Augusti and CFO Bob Howe will present at the Canaccord Genuity Musculoskeletal Conference on May 20, 2021, at 10:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Conformis, Inc. (NASDAQ: CFMS), a leader in personalized orthopedic medical devices, announced that CEO Mark Augusti and CFO Bob Howe will present at the Canaccord Genuity Musculoskeletal Conference on May 20, 2021, at 10:30 a.m. ET. A live webcast will be available, and one-on-one meetings with management can be arranged. Conformis specializes in developing customized knee and hip replacements using its proprietary iFit® technology, delivering individually sized implants to accommodate unique patient anatomies.
Details
News Market Reaction – CFMS
The recorded move for CFMS in the trading session of this news was -3.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference.
The virtual presentation is scheduled for Thursday, May 20, 2021 at 10:30 a.m. ET. A live webcast of the presentation will be available at https://wsw.com/webcast/canaccord54/cfms/2442655.
Conformis management will also be available for one-on-one meetings throughout the conference. For more information about the conference or to schedule a one-on-one meeting with management, please contact your Canaccord representative or Conformis Investor Relations at ir@conformis.com and (781) 374-5598.
The live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Conformis website at ir.conformis.com. The replay of the webcast will be archived on Conformis' website for 30 days following the presentation.
About Conformis, Inc.
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit and conform to each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
For more information, visit www.comformis.com. To receive future releases in e-mail alerts, sign up at ir.conformis.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.